P M Ellis

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi Diffusion and dissemination of evidence-based dietary strategies for the prevention of cancer
    Donna Ciliska
    School of Nursing, McMaster University, 1200 Main St W Hamilton, Ontario, L8N 3Z5, Canada
    Nutr J 4:13. 2005
  2. ncbi Advocacy for clinical trials: do the Royal Colleges and State cancer councils play an appropriate role?
    P M Ellis
    Hamilton Regional Cancer Centre, Ontario, Canada
    Aust N Z J Public Health 25:9-11. 2001
  3. ncbi Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate
    P M Ellis
    Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada
    J Clin Oncol 19:3554-61. 2001
  4. ncbi Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet
    P M Ellis
    Medical Oncologist Hamilton Regional Cancer Center, Hamilton, Ontario, Canada
    Ann Oncol 13:1414-23. 2002
  5. ncbi Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000
    P M Ellis
    Department of Medical Oncology, Liverpool Hospital, Sydney, New South Wales, Australia
    Australas Radiol 48:364-70. 2004
  6. ncbi Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline
    J Noble
    , Regional Cancer Program, Sudbury, ON, Canada
    J Thorac Oncol 1:1042-58. 2006

Collaborators

  • Martin N Tattersall
  • G P Delaney
  • J Noble
  • Donna Ciliska
  • J A Mackay
  • W K Evans
  • Paula Robinson
  • Melissa Brouwers
  • Mary Gauld
  • Fulvia Baldassarre
  • Parminder Raina
  • Tanya Armour

Detail Information

Publications6

  1. ncbi Diffusion and dissemination of evidence-based dietary strategies for the prevention of cancer
    Donna Ciliska
    School of Nursing, McMaster University, 1200 Main St W Hamilton, Ontario, L8N 3Z5, Canada
    Nutr J 4:13. 2005
    ..The purpose was to determine what strategies have been evaluated to disseminate cancer control interventions that promote the uptake of adult healthy diet?..
  2. ncbi Advocacy for clinical trials: do the Royal Colleges and State cancer councils play an appropriate role?
    P M Ellis
    Hamilton Regional Cancer Centre, Ontario, Canada
    Aust N Z J Public Health 25:9-11. 2001
    ..Endorsement of clinical trials by prominent local or national organisations may help to promote public awareness of and enhance patient and doctor participation in randomised trials...
  3. ncbi Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate
    P M Ellis
    Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada
    J Clin Oncol 19:3554-61. 2001
    ..To explore the association at different time points in the trajectory of breast cancer care, between anxiety, knowledge, and attitudes, on women's willingness to participate in randomized clinical trials...
  4. ncbi Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet
    P M Ellis
    Medical Oncologist Hamilton Regional Cancer Center, Hamilton, Ontario, Canada
    Ann Oncol 13:1414-23. 2002
    ..To evaluate the impact of an educational booklet on women's knowledge of and willingness to participate in a randomized clinical trial of treatment for breast cancer...
  5. ncbi Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000
    P M Ellis
    Department of Medical Oncology, Liverpool Hospital, Sydney, New South Wales, Australia
    Australas Radiol 48:364-70. 2004
    ..9 months (95%CI: 7.5-10.2) for ED. Some health outcomes similar to that reported in clinical trials can be achieved in clinical practice. Measuring health outcomes is an important process of maintaining quality of care...
  6. ncbi Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline
    J Noble
    , Regional Cancer Program, Sudbury, ON, Canada
    J Thorac Oncol 1:1042-58. 2006
    ..CONCLUSION: Second-line or subsequent therapy with single-agent docetaxel, pemetrexed, or erlotinib offers patients a significant survival and QOL advantage...